Key terms

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CORT news

Yesterday 8:11am ET Corcept Therapeutics completes enrollment in Phase 2 DAZALS trial by TipRanks Apr 11 6:00pm ET Upcoming Deadline to Share in Corcept Therapeutics Incorporated (CORT) Class Action Settlement by TipRanks Apr 08 8:11am ET Corcept Therapeutics completes enrollment in Phase 3 ROSELLA trial by TipRanks Apr 01 8:10am ET Corcept Therapeutics completes enrollment in Phase 3 GRADIENT trial by TipRanks Mar 20 5:55am ET Corcept Therapeutics management to meet with Truist by TipRanks Mar 18 8:24am ET Corcept Therapeutics management to meet with Truist by TipRanks Mar 18 7:45am ET Truist Financial Gives a Buy Rating to Corcept Therapeutics (CORT) by TipRanks Feb 17 1:00am ET Bad News for Corcept Therapeutics Stock: This New Risk Has Been Added by TipRanks Feb 16 7:45am ET Corcept Therapeutics price target raised to $42 from $36 at Truist by TipRanks Feb 16 7:10am ET Analysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Bio-Rad Laboratories (BIO) by TipRanks Feb 16 6:20am ET Analysts’ Top Healthcare Picks: AngioDynamics (ANGO), Corcept Therapeutics (CORT) by TipRanks Feb 16 6:14am ET Corcept Therapeutics price target raised to $38 from $28 at H.C. Wainwright by TipRanks Feb 15 4:52pm ET Corcept Therapeutics announces preliminary results from CATALYST study by TipRanks Feb 15 4:45pm ET Corcept Therapeutics reports Q4 EPS 28c, consensus 26c by TipRanks Feb 15 4:23pm ET Corcept Therapeutics Reports Latest Quarterly Results and Update by TipRanks Jan 24 1:29am ET Corcept Therapeutics: Hold Rating Amidst Generic Competition and Legal Challenges by TipRanks Jan 23 7:40am ET Wall Street Analysts Are Bullish on Top Healthcare Picks by TipRanks Jan 23 6:25am ET Corcept Therapeutics price target lowered to $23 from $27 at Leerink by TipRanks

No recent news articles are available for CORT

Today 12:30pm ET Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement by Accesswire

CORT Financials

1-year income & revenue

Key terms

CORT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CORT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments